Loading...
No More Tears: The Dark Secrets of Johnson & Johnson Audiobook, by Gardiner Harris Play Audiobook Sample

No More Tears: The Dark Secrets of Johnson & Johnson Audiobook

No More Tears: The Dark Secrets of Johnson & Johnson Audiobook, by Gardiner Harris Play Audiobook Sample
FlexPass™ Price: $20.95
$11.95 for new members!
(Includes UNLIMITED podcast listening)
  • Love your audiobook or we'll exchange it
  • No credits to manage, just big savings
  • Unlimited podcast listening
Add to Cart
$11.95/m - cancel anytime - 
learn more
OR
Regular Price: $26.00 Add to Cart
Read By: Gardiner Harris Publisher: Random House Audio Listen Time: at 1.0x Speed 9.67 hours at 1.5x Speed 7.25 hours at 2.0x Speed Release Date: April 2025 Format: Unabridged Audiobook ISBN: 9798217065332

Quick Stats About this Audiobook

Total Audiobook Chapters:

43

Longest Chapter Length:

57:54 minutes

Shortest Chapter Length:

15 seconds

Average Chapter Length:

20:04 minutes

Audiobooks by this Author:

1
Love Gardiner Harris? Discover more! Ask Scout to find audiobooks like "No More Tears" or other titles with a similar vibe.

Publisher Description

NEW YORK TIMES BESTSELLER • An explosive, deeply reported exposé of Johnson & Johnson, one of America’s oldest and most trusted pharmaceutical companies—from an award-winning investigative journalist

“A damning portrait.”—Associated Press


“A page-turning drama that raises life-or-death questions about the world’s largest healthcare conglomerate.”—Jonathan Eig, Pulitzer Prize–winning author of King: A Life

FINALIST FOR THE NATIONAL BOOK CRITICS CIRCLE AWARD AND THE LOS ANGELES TIMES BOOK PRIZE • A CHICAGO PUBLIC LIBRARY AND NEW YORK PUBLIC LIBRARY BEST BOOK OF THE YEAR

One day in 2004, Gardiner Harris, a pharmaceutical reporter for The New York Times, was early for a flight and sat down at an airport bar. He struck up a conversation with the woman on the barstool next to him, who happened to be a drug sales rep for Johnson & Johnson. Her horrific story about unethical sales practices and the devastating impact they’d had on her family fundamentally changed the nature of how Harris would cover the company—and the entire pharmaceutical industry—for the Times. His subsequent investigations and ongoing research since that very first conversation led to this book—a blistering exposé of a trusted American institution and the largest healthcare conglomerate in the world.

Harris takes us light-years away from the company’s image as the child-friendly “baby company” as he uncovers reams of evidence showing decades of deceitful and dangerous corporate practices that have threatened the lives of millions. He covers multiple disasters: lies and cover-ups regarding the link of Johnson’s Baby Powder to cancer, the surprising dangers of Tylenol, a criminal campaign to sell antipsychotics that have cost countless lives, a popular drug used to support cancer patients that actually increases the risk that cancer tumors will grow, and deceptive marketing that accelerated opioid addictions through their product Duragesic (fentanyl) that rival even those of the Sacklers and Purdue Pharma.

Filled with shocking and infuriating but utterly necessary revelations, No More Tears is a landmark work of investigative journalism that lays bare the deeply rooted corruption behind the image of babies bathing with a smile.

Download and start listening now!

"As a retired Pharmacist, Emeritus Dean and former American Pharmacists Association with 50 years of related industry experience this book explains my growing skepticism about our Big Pharma industry. Having lost an older brother to schizophrenia after decades of heartache who took Risperdal off and on for years and died in a group home after what was likely a heart attack in his sleep, I am angry. I’ll do everything I can to get other leaders in Pharmacy to read or listen to this book. It is a devastating indictment of the FDA, Big Pharma and our regulatory and justice system. "

— Ronald P jordan (5 out of 5 stars)

Quotes

  • “A damning portrait…A valuable history that’s not limited to Johnson & Johnson and helps for a broader understanding of today’s health-care system.”

    — Associated Press
  • “A masterpiece of muckraking…Harris supports his takedown with a mountain of evidence and conveys his findings in scorching prose.”

    — Publishers Weekly (starred review)
  • “Full of epiphanies and scientific truths, this expose of Johnson and Johnson’s ubiquitous reach is a must-read.”

    — Library Journal (starred review)
  • “It is very nearly impossible to believe that this company could be capable of so many layers of deceit and dishonesty, yet that is exactly what Harris lays bare in this masterfully researched title with a narrative akin to a thriller in its intensity…Absolutely unforgettable.”

    — Booklist (starred review)
  • “A page-turning drama that raises life-or-death questions about the world’s largest health-care conglomerate.”

    — Jonathan Eig, Pulitzer Prize winner and #1 New York Times bestselling author

Awards

  • A New York Times Bestseller
  • An Amazon Bestseller
  • An Amazon Editors' Pick of Best Books of the Year (So Far)

No More Tears Listener Reviews

Be the first to write a review about this audiobook!

About Gardiner Harris

Gardiner Harris won the Worth Bingham Prize for investigative journalism and the George Polk Award for environmental reporting after revealing that coal companies deliberately and illegally exposed miners to toxic levels of coal dust. His novel, Hazard, draws on his experience investigating these conditions. Now a freelance investigative journalist, he previously served at the New York Times as the public health and pharmaceutical reporter and a White House, South Asia, and international diplomacy reporter. Before that, he was a reporter for the Wall Street Journal, covering the pharmaceutical industry. His investigations there led to what was then the largest fine in the history of the Securities and Exchange Commission. Previously, he was the Appalachian reporter for the Courier-Journal of Louisville, Kentucky. He has also been a Pulitzer Prize finalist with a team of others at the New York Times.